Remove Innovations Remove Office Remove Portfolios
article thumbnail

Breaking Business News: Crown Laboratories to Buy Revance Therapeutics in $924 Million Merger Deal

The Dermatology Digest

“Revance has an impressive track record in developing innovative aesthetics offerings that will complement Crown’s innovative line of skincare products. Crown shares our commitment to innovation and scale and will help us accelerate our growth. ” Mark J.

article thumbnail

Done Deal: Organon Completes Acquisition of Dermavant

The Dermatology Digest

The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Crown Forms Unified Consumer Skincare Division

The Dermatology Digest

The new Consumer Skincare Division, led by Steve Gallopo, Executive Vice President and Chief Commercial Officer, will combine resources of the previously separate units. Crown Laboratories, Inc. is consolidating its Premium Skincare and Therapeutic business units into a single Consumer Skincare Division.

article thumbnail

Alexis (Lexi) Stern Named New CMO at Merz Aesthetics

The Dermatology Digest

Alexis (Lexi) Stern is Merz Aesthetics’ new Chief Marketing Officer. Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Stern will report directly to Bob Rhatigan, Chief Executive Officer, Merz Aesthetics. Most recently, Ms.

Office 36
article thumbnail

Incyte, CMS Partner to Develop Povorcitinib in Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia

The Dermatology Digest

“We are excited to announce the addition of this collaboration for povorcitinib, expanding our relationship with CMS in the Dermatology space beyond ruxolitinib cream, to include two products with the potential to help patients with limited treatment options,” says Hervé Hoppenot, Chief Executive Officer, Incyte, in a news release.

article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

Dennis Gross Skincare is the perfect complement to our global portfolio of prestige brands as their core values are aligned with ours in terms of their scientific and innovative approach to beauty and our people-first culture.” Meet Spiderwort’s CelluJuve Clinical Advisory Board Spiderwort Inc.

article thumbnail

Hilton’s Amanda Al Masri talks about 2025 travel trends

Spa Executive

Travelers don’t just want to choose their own adventure – they want to maximize every moment of their time away,” said Chris Nassetta, president and chief executive officer, Hilton. Hilton’s 2025 Trends Report unveils the rising travel trends predicted to ignite conversation and innovation while reshaping the travel experience in 2025.